DE-ESCALATE: INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHAS...
GRUPO ESPANOL DE TRATAMIENTO DE TUMORES UROLOGICOS ASOCIACION
participó en un
HORIZON EUROPE:
HORIZON-MISS-2022-CANCER-01
Prostate Cancer is the most common cancer in European men. Despite dramatic improvements in early diagnostic and local treatment, one out of...
2023-04-21 - 2028-05-31 | Financiado
2023-04-21 - 2028-05-31 | Financiado
EUROTARGET: European collaborative project on Targeted therapy in renal cell cancer genetic and tumor related b...
GRUPO ESPANOL DE TRATAMIENTO DE TUMORES UROLOGICOS ASOCIACION
participó en un
FP7:
Each year more than 63,000 new cases of kidney cancer are diagnosed in the European Union. Approx. 50% of all patients have metastasized ren...
Financiado
Financiado
* No se disponen de datos de la empresa actual.